Toxicokinetics and metabolism of N-[14C]N-methyl-2-pyrrolidone in male Sprague-Dawley rats: In vivo and in vitro percutaneous absorption

Drug Metabolism and Disposition

Volumn 31, Issue 5, 2003, Pages 659-669

  Payan, Jean Paul ^a   Boudry, Isabelle ^a   Beydon, Dominique ^a   Fabry, Jean Paul ^a   Grandclaude, Marie Christine ^a   Ferrari, Elisabeth ^a   André, Jean Claude ^a  

^a INSTITUT NATIONAL DE RECHERCHE ET DE SÉCURITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 2 PYRROLIDINONE; 2 PYRROLIDONE DERIVATIVE; CARBON 14;

ANIMAL TISSUE; CONFERENCE PAPER; DIFFUSION; DILUTION; DRUG METABOLISM; MALE; MATHEMATICAL MODEL; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SKIN ABSORPTION; SKIN PENETRATION; SKINFOLD THICKNESS; TOXICOKINETICS; WATER TRANSPORT;

ADMINISTRATION, CUTANEOUS; ANIMALS; CARBON RADIOISOTOPES; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MODELS, BIOLOGICAL; PYRROLIDINONES; RATS; RATS, SPRAGUE-DAWLEY; SKIN ABSORPTION; TIME FACTORS; WATER;

ANIMALIA;

EID: 0037403454     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.31.5.659     Document Type: Conference Paper

References (14)

1. Akesson B and Paulsson K (1997) Experimental exposure of male volunteers to N-methyl-2-pyrrolidone (NMP): acute effects and pharmacokinetics of NMP in plasma and urine. Occup Environ Med 54:236-240.
2. Akesson B and Jonsson BA (1997) Major metabolic pathway for N-methyl-2-pyrrolidone in humans. Drug Metab Dispos 25:267-269.
3. Barry BW and Bennett L (1987) Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progesterone through human skin. J Pharm Pharmacol 39:535-546.
4. 50 of ethanol, diethylacetamide, dimethylformamide, dimethylsulfoxide, glycerine, N-methylpyrrolidone, polyethylene glycol 400, 1,2-propanediol and Tween 20. Arzneim-Forsch 26:1581.
5. Bourds SVJ, Griffiths J, McCarthy T, Lorman A, and Parod R (1999) Dermal absorption of N-methylpyrrolidone (NMP) in rat, 38th Annual Meeting of the Society of Toxicology, New Orleans, LA, 1999, March 14-18; Abstracts, p 72, Toxicol Sci 481.
6. Bower DB (1997) Stillbirth after occupational exposure to N-methyl-2 pyrrolidone. J Occup Environ Med 39:393-394.
7. Hass U, Lund SP, and Elsner J (1994) Effects of prenatal exposure to N-methylpyrrolidone on postnatal development and behavior in rats. Neurotoxicol Teratol 16:241-249.
8. 14C]pyrrolidinone in the rat. Food Chem Toxicol 30:57-64.
9. 14C]methylpyrrolidone in male Sprague-Dawley rats. A saturable NMP elimination process Drug Metab Disp 30:1418-1424.
10. Roberts MS, Anissimov YG, and Gonsalvez RA (1999) Mathematical models in percutaneous absorption, in Percutaneous Absorption Drugs-Cosmetics-Mechanisms-Methodology, 3rd ed (Bronaugh RL and Maibach HI eds) vol 97, pp 3-55, Drugs and the Pharmaceutical Sciences, Marcel Dekker, Inc., New York.
11. Solomon HM, Burgess BA, Kennedy GL, and Staples RE (1995) 1-Methyl-2-pyrrolidone (NMP): reproductive and developmental toxicity study by inhalation in the rat. Drug Chem Toxicol 18:271-293.
12. Sugibayashi K, Sakanoue C, and Morimoto Y (1989) Utility of topical formulation of morphine hydrochloride containing azone and N-methylpyrrolidone. Sel Cancer Ther 5:119-128.
13. Ursin C, Hansen CM, Van Dyk JW, Jensen PO, Christensen IJ, and Ebbehoej J (1995) Permeability of commercial solvents through living human skin. Am Ind Hyg Assoc J 56:651-660.
14. Wells DA, Hawi AA, and Digenis GA (1992) Isolation and identification of the major urinary metabolite of N-methylpyrrolidone in the rat. Drug Metab Dispos 20:124-126.